Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk

Rachel Shukrun(Tel Aviv University), Naomi Pode‐Shakked(Tel Aviv University), Oren Pleniceanu(Tel Aviv University), Dorit Omer(Tel Aviv University), Einav Vax(Tel Aviv University), Eyal Peer(Tel Aviv University), Sara Pri‐Chen(Sheba Medical Center), Jasmine Jacob(Sheba Medical Center), Qianghua Hu(The University of Texas MD Anderson Cancer Center), Orit Harari‐Steinberg(Sheba Medical Center), Vicki Huff(The University of Texas MD Anderson Cancer Center), Benjamin Dekel(Tel Aviv University)
Stem Cell Reports
June 26, 2014
Cited by 56Open Access
Full Text

Abstract

An open question remains in cancer stem cell (CSC) biology whether CSCs are by definition at the top of the differentiation hierarchy of the tumor. Wilms' tumor (WT), composed of blastema and differentiated renal elements resembling the nephrogenic zone of the developing kidney, is a valuable model for studying this question because early kidney differentiation is well characterized. WT neural cell adhesion molecule 1-positive (NCAM1(+)) aldehyde dehydrogenase 1-positive (ALDH1(+)) CSCs have been recently isolated and shown to harbor early renal progenitor traits. Herein, by generating pure blastema WT xenografts, composed solely of cells expressing the renal developmental markers SIX2 and NCAM1, we surprisingly show that sorted ALDH1(+) WT CSCs do not correspond to earliest renal stem cells. Rather, gene expression and proteomic comparative analyses disclose a cell type skewed more toward epithelial differentiation than the bulk of the blastema. Thus, WT CSCs are likely to dedifferentiate to propagate WT blastema.


Related Papers

No related papers found

Powered by citation graph analysis